Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Ophthalmology 2014 Apr 121 (4): 905-10.
Hermann Manuel M, van Asten Freekje, Muether Philipp S, Smailhodzic Dzenita, Lichtner Peter, Hoyng Carel B, Kirchhof Bernd, Grefkes Christian, den Hollander Anneke I, Fauser Sasc
- Page last reviewed:Jul 30, 2019
- Page last updated:Sep 18, 2019
- Content source: